Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. [electronic resource]
Producer: 20051110Description: 263-7 p. digitalISSN:- 1541-6933
- Aged
- Aged, 80 and over
- Anticoagulants -- adverse effects
- Antifibrinolytic Agents -- therapeutic use
- Drug Therapy, Combination
- Factor VII -- administration & dosage
- Factor VIIa
- Female
- Humans
- International Normalized Ratio
- Intracranial Hemorrhages -- chemically induced
- Male
- Middle Aged
- Plasma
- Recombinant Proteins -- administration & dosage
- Retrospective Studies
- Treatment Outcome
- Vitamin K -- therapeutic use
- Warfarin -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.